Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Running, not enrolling
Conditions studied: Migraine
In brief
The purpose of the study is to evaluate the risk of pregnancy and infant outcomes among women with migraine exposed to rimegepant during pregnancy and in two rimegepant unexposed comparator groups.
Key facts
- Study ID
- NCT05198245
- Run by
- Pfizer
- People needed
- 1
- Starts
- 2021-12-15
- Expected to finish
- 2028-04-17
- Last updated by the study team
- 2026-01-08
Who can join
Age: 16 and older, up to 49. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Pfizer — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.